期刊文献+

杂交瘤细胞株功能性与非功能性V_K基因结构分析 被引量:4

Sequence analysis of functional and nonfunctional V K genes from a hybridoma
下载PDF
导出
摘要 目的:探讨不同引物从杂交瘤细胞株中扩增出功能性和非功能性VK基因的关系。方法:利用RTPCR技术扩增出轻链可变区基因,测序后,利用DNASIS7和与GenBank比较分析。结果:发现引物(VL5′.1和JK1/2)扩增出了非功能性VK基因。而改用引物(VL5′.2和VL3′)后,扩增出了有功能的VK基因。结论:非功能性VK基因的扩增,说明部分杂交瘤细胞出现了来源于原融合细胞的基因异常重排。在制备基因工程抗体中,区别功能性和非功能性VK基因具有重要意义。 Objective:To find the relationship between functional and non functional V K genes which were cloned from a hybridoma(7579) with two different kinds of family specific primers.Methods:From a secreting mouse hybridoma cell line 7579, total RNA was prepared and was reverse transcribed into the first strand of cDNAs. The V L genes was amplified by PCR with family specific primers, and then cloned into the pGEM T vectors in the competent cell JM109. With the dye terminator cycle sequencing method, the V L gene was sequenced. The results was analyzed with DNASIS7, and also was compared with the NIH's GenBank .Results:A non functional V K, which was amplified with the primers V L5′.1 and J K1/2, was found. It exhibited 98% homology to the BALB/c V K 21 E. However there are 4 bp deletion at it's V/J junction leading to a frame shift. This results in a premature termination codon at following position. Using different family specific primers, a functional V K gene was obtained. Conclusion:Analysis of the two kinds of V K genes suggests that the functional V K gene is derived from the B cell and the non functional arises from an aberrent mRNA transcript which is present in all standard fusion partners derived from the original MOPC 21 tumor.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 1999年第2期82-84,共3页 Chinese Journal of Immunology
关键词 VK基因 序列分析 单克隆抗体 杂交瘤 免疫球蛋白 V K gene Sequence analysis Antibody,monoclonal
  • 相关文献

参考文献3

共引文献7

同被引文献28

  • 1[3]Weiner LM. An overview of monoclonal antibody therapy of cancer[J]. Semin Oncol, 1999,26(suppl 12):41.
  • 2[4]Lobuglio AF, Wheeler RH, Trang J, et al. Mouse/human chimeric monoclonal antibody in man: Kinetics and immune response[J]. PNAS. USA, 1989, 86:4220-4224.
  • 3[5]Knight DM, Trinh H, Le J, et al. Construction and initial characterization of a mouse-human chimeric antiTNF antibody[J]. Mole Immunol, 1993, 30(16):1443-1453.
  • 4[6]Meredith RF,Lobuglio AF, Plott WE, et al.Pharmacokinetics, immune response, and biodistribution of iodine131-labeled chimeric mouse/human IgG1, k 17-1Amonoclonal antibody[J ]. J Nucl Med, 1991,32 : 1162-1168.
  • 5[7]Meredith RF, Khazaeli MB, Plott WE. Initial clinical evaluation of iodine-125-1abeled chimeric 17-1A for metastatic colon cancer[J]. J Nucl Med, 1995,36:2229-2233.
  • 6[8]Goding J W. Monoclonal antibody OKT-9 recognizes the receptor for transferrin on human acture lymphocytic leukemia cells[J]. J Immunol, 1981,127(3): 1256-1258.
  • 7[9]Scheider C. Structural features of the cell surface receptor for transferrin that is recognized by the monoclonal antibody OKT-9[J]. J Bio Chem, 1982,257(14): 8516-8522.
  • 8[10]Simonart T,Degraef C,Andrei G, et al. Iron chela-tors inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors[J]. J Invest Dermatol, 2000,115(5):893-900.
  • 9[11]Kovar J,Stunz LL,Stewart BC, et al. Direct evide-nce that iron deprivation induces apoptosis in murine lymphoma 38C13 [ J ]. Pathobiology 1997,65 (2) : 61 -68.
  • 10[12]Le NT, Richardson DR. The role of iron in cell cycle progression and the proliferation of neoplastic cells[J].Biochim Biophys Acta, 2002,1603(1): 31-46.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部